105 related articles for article (PubMed ID: 2827482)
1. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
Shoupe D; Mishell DR; Page MA; Madkour H; Spitz IM; Lobo RA
Am J Obstet Gynecol; 1987 Dec; 157(6):1421-6. PubMed ID: 2827482
[TBL] [Abstract][Full Text] [Related]
2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
Permezel JM; Lenton EA; Roberts I; Cooke ID
J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation.
Batista MC; Cartledge TP; Zellmer AW; Nieman LK; Merriam GR; Loriaux DL
J Clin Endocrinol Metab; 1992 Mar; 74(3):565-70. PubMed ID: 1740491
[TBL] [Abstract][Full Text] [Related]
6. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
7. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.
Shoupe D; Mishell DR; Lahteenmaki P; Heikinheimo O; Birgerson L; Madkour H; Spitz IM
Am J Obstet Gynecol; 1987 Dec; 157(6):1415-20. PubMed ID: 2827481
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?
Collins RL; Hodgen GD
J Clin Endocrinol Metab; 1986 Dec; 63(6):1270-6. PubMed ID: 3097053
[TBL] [Abstract][Full Text] [Related]
9. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration.
Danforth DR; Dubois C; Ulmann A; Baulieu EE; Hodgen GD
Contraception; 1989 Aug; 40(2):195-200. PubMed ID: 2503298
[TBL] [Abstract][Full Text] [Related]
11. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
12. Luteal contraception.
Yen S; Garzo G; Liu J
Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
[TBL] [Abstract][Full Text] [Related]
13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
14. Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle.
Stuenkel CA; Garzo VG; Morris S; Liu JH; Yen SS
Fertil Steril; 1990 Apr; 53(4):642-6. PubMed ID: 2156736
[TBL] [Abstract][Full Text] [Related]
15. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
16. Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.
Healy DL; Baulieu EE; Hodgen GD
Fertil Steril; 1983 Aug; 40(2):253-7. PubMed ID: 6307760
[TBL] [Abstract][Full Text] [Related]
17. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
18. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys.
Remohi J; Balmaceda JP; Rojas FJ; Asch RH
Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390
[TBL] [Abstract][Full Text] [Related]
19. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]